Evaluation of the effect of two herbal medicine on the climacteric symptoms and sexual activity in menopausal women

Comparison of the effect of Foeniculum vulgare and St John’s wort (Hypericum perforatum) on the climacteric symptoms and sexual activity in menopausal woman attending in selected gynecology clinics of shiraz university of medical sciences,1391.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201207281548N15

Enrollment

105

Registered

2012-08-25

Start date

2012-08-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

menopause. Symptoms such as flushing, sleeplessness, headache, lack of concentration, associated with menopause

Interventions

Intervention 1: Oral placebo tablets three times daily for 8 weeks. Intervention 2: Fennel, soft capsule, 30 mg orally, three times daily for 8 weeks. Intervention 3: Hypericum perforatum,160 mg oral

Treatment - Drugs

Placebo

Oral placebo tablets three times daily for 8 weeks

Fennel, soft capsule, 30 mg orally, three times daily for 8 weeks

Hypericum perforatum,160 mg oral tablet, three times daily for 8 weeks

Eligibility

Sex/Gender

Female

Age

45 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: having general health according to the Goldberg's questionnaire; i.e., getting under23 score, being married and between 40 and 60 years old, not using vitamin supplements, not using soya, not having used hormone therapy during the last 3 months, not using anti-depression,and tranquilizer drugs, amenorrhea for at least 6 months, and FSH more than 40. Exclusion criteria: Suffering from liver, kidney, and digestive diseases, inability to continue taking medication for any reason, unwillingness to cooperate after the beginning of the study, and showing allergic reactions to medication.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Improvement of clinical symptoms. Timepoint: 4 weeks. Method of measurement: Green Questionnaire.	—

Secondary

Measure	Time frame
Improve sexual function. Timepoint: 4 weeks. Method of measurement: Female Sexual Function Index.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactKhadijeh Abdali

Fatemeh College of nursing and midwifery

abdalikh@sums.ac.ir+98 71164742547

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026